메뉴 건너뛰기




Volumn 397, Issue 6, 2010, Pages 2191-2197

Daptomycin determination by liquid chromatography-mass spectrometry in peritoneal fluid, blood plasma, and urine of clinical patients receiving peritoneal dialysis treatment

Author keywords

Daptomycin; LC MS; Peritoneal dialysis; Peritoneal fluid; Pharmacokinetics; Plasma; Urine

Indexed keywords

DAPTOMYCIN; LC-MS; PERITONEAL DIALYSIS; PERITONEAL FLUID; URINE;

EID: 77955981074     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-010-3639-2     Document Type: Article
Times cited : (35)

References (13)
  • 1
    • 0033790259 scopus 로고    scopus 로고
    • 10.1093/jac/46.4.523 1:CAS:528:DC%2BD3cXnsl2ktbo%3D
    • FP Tally MF DeBruin 2000 J Antimicrob Chemother 46 523 526 10.1093/jac/46.4.523 1:CAS:528:DC%2BD3cXnsl2ktbo%3D
    • (2000) J Antimicrob Chemother , vol.46 , pp. 523-526
    • Tally, F.P.1    Debruin, M.F.2
  • 3
    • 4544230403 scopus 로고    scopus 로고
    • Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections
    • 10.1517/13543784.13.9.1159
    • BI Eisenstein 2004 Expert Opin Investig Drugs 13 1159 1169 10.1517/13543784.13.9.1159 1:CAS:528:DC%2BD2cXmvFSmsrc%3D (Pubitemid 39242739)
    • (2004) Expert Opinion on Investigational Drugs , vol.13 , Issue.9 , pp. 1159-1169
    • Eisenstein, B.I.1
  • 6
    • 33749534709 scopus 로고    scopus 로고
    • Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers
    • 10.1128/AAC.00247-06
    • M Benvenuto DP Benziger S Yankelev G Vigliani 2006 Antimicrob Agents Chemother 50 3245 3249 10.1128/AAC.00247-06 1:CAS:528:DC%2BD28XhtVylsbrE (Pubitemid 44527494)
    • (2006) Antimicrobial Agents and Chemotherapy , vol.50 , Issue.10 , pp. 3245-3249
    • Benvenuto, M.1    Benziger, D.P.2    Yankelev, S.3    Vigliani, G.4
  • 7
    • 0037378761 scopus 로고    scopus 로고
    • Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects
    • 10.1128/AAC.47.4.1318-1323.2003
    • BH Dvorchik D Brazier MF DeBruin RD Arbeit 2003 Antimicrob Agents Chemother 47 1318 1323 10.1128/AAC.47.4.1318-1323.2003 1:CAS:528: DC%2BD3sXivVSmsr8%3D (Pubitemid 36368592)
    • (2003) Antimicrobial Agents and Chemotherapy , vol.47 , Issue.4 , pp. 1318-1323
    • Dvorchik, B.H.1    Brazier, D.2    DeBruin, M.F.3    Arbeit, R.D.4
  • 8
    • 2942640370 scopus 로고    scopus 로고
    • Moderate liver impairment has no influence on daptomycin pharmacokinetics
    • 10.1177/0091270004266619
    • B Dvorchik 2004 J Clin Pharmacol 44 715 722 10.1177/0091270004266619 1:CAS:528:DC%2BD2cXlslamsL0%3D (Pubitemid 38765933)
    • (2004) Journal of Clinical Pharmacology , vol.44 , Issue.7 , pp. 715-722
    • Dvorchik, B.1    Robertson, M.2
  • 9
    • 16644367133 scopus 로고    scopus 로고
    • 10.1177/0091270004269562 1:CAS:528:DC%2BD2MXks1Sls7w%3D
    • BH Dvorchik D Damphousse 2005 J Clin Pharmacol 45 48 56 10.1177/0091270004269562 1:CAS:528:DC%2BD2MXks1Sls7w%3D
    • (2005) J Clin Pharmacol , vol.45 , pp. 48-56
    • Dvorchik, B.H.1    Damphousse, D.2
  • 10
    • 33646380084 scopus 로고    scopus 로고
    • The protein-binding and drug release properties of macromolecular conjugates containing daptomycin and dextran
    • 10.1016/j.ijpharm.2006.02.016, PII S0378517306001396
    • W Muangsiri LE Kirsch 2006 Int J Pharm 315 30 43 10.1016/j.ijpharm.2006. 02.016 1:CAS:528:DC%2BD28XksFyhs7g%3D (Pubitemid 43674119)
    • (2006) International Journal of Pharmaceutics , vol.315 , Issue.1-2 , pp. 30-43
    • Muangsiri, W.1    Kirsch, L.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.